Novartis Reports a Stunning 40% Surge in Q1 EPS, Reaching $1.83 Amid Market Optimism
Novartis achieves a 40% EPS growth in Q1, reaching $1.83, showcasing strong performance and strategic growth in the pharmaceutical sector. More details to follow.
Novartis achieves a 40% EPS growth in Q1, reaching $1.83, showcasing strong performance and strategic growth in the pharmaceutical sector. More details to follow.
Indian equity benchmarks BSE Sensex and Nifty50 opened strongly, with significant gains influenced by robust corporate performance and positive stock movements. Global markets show...
Gold investments, especially those made on auspicious occasions like Akshaya Tritiya, have yielded significant returns over the years. With prices reaching new highs, gold proves t...
IndusInd Bank's Deputy CEO Arun Khurana resigns following a Rs 2,000-crore accounting lapse from derivative trades, as an independent investigation confirms financial discrepancies...
RBI Deputy Governor M Rajeshwar Rao discusses the challenges of balancing green finance promotion with managing credit risks in the transition to green technology, highlighting the...
Top brokerage firms highlight key stocks for April 29, including Reliance Industries, Maruti, IDFC First Bank, Mahindra & Mahindra, and Shriram Finance, with varied ratings and tar...
Discover the top stock picks for April 29, 2025, featuring Canara Bank and Bharat Forge. Expert analysis suggests potential upside breakouts and continued upward trends for these s...
The Reserve Bank of India (RBI) announces a Rs 1.25 lakh crore government securities buyback in May to support banking system liquidity, following April's liquidity-easing measures...